Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct;17(10):2619-27.
doi: 10.1245/s10434-010-1121-1. Epub 2010 May 25.

Higher expression of the heterogeneous nuclear ribonucleoprotein k in melanoma

Affiliations

Higher expression of the heterogeneous nuclear ribonucleoprotein k in melanoma

Fushi Wen et al. Ann Surg Oncol. 2010 Oct.

Abstract

Background: The heterogeneous nuclear ribonucleoprotein (hnRNP) K is an essential RNA and DNA binding protein involved in gene expression and signal transduction. The role of hnRNP K in cancer is relatively understudied. However, several cellular functions strongly indicate that hnRNP K is involved in tumorigenesis. Oncogenes c-Src, c-myc, and eIF4E are regulated by hnRNP K. We have shown an increased cytoplasmic hnRNP K in pancreatic cancer. In the present study, we investigated the altered expression of hnRNP K protein and its correlation with p-ERK in melanoma using human melanoma cell lines and tissue microarray.

Materials and methods: The protein levels of hnRNP K and p-ERK in 8 human melanoma cell lines and a melanoma progression tissue microarray containing 80 melanoma, 23 dysplastic nevi, and 14 benign nevi specimens were analyzed using Western blot and immunohistochemistry analysis. hnRNP K was knocked down by siRNA, and its effect on melanoma cells was assessed.

Results: We showed a higher hnRNP K protein level in both melanoma cell lines and melanoma tissue specimens, which correlated with a higher c-myc expression. An increase in the cytoplasmic hnRNP K and eIF4E protein levels in melanoma cells is also seen. p-ERK level was also higher in dysplastic nevi and melanoma tissues, but did not correlate with hnRNP K protein level. We then demonstrated that knocking down of hnRNP K by siRNA inhibited melanoma cell growth and colony formation, as well as c-myc expression.

Conclusions: hnRNP K expression correlated with melanoma and may play a role in melanoma tumorigenesis.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Higher hnRNP K protein level in human melanoma cell lines. Primary fibroblast, primary normal melanocytes, and 8 melanoma cell lines were grown at the log phase and harvested. Western blot analysis was performed using hnRNP K, c-myc, eIF4E, p-ERK, ERK1/2, and α-tubulin antibodies. The intensities of the bands were quantified using ImageJ software and normalized to α-tubulin. The ratio to tubulin was indicated below each band. ERK1/2 was measured as 1 band because of the close distance between these 2 bands
FIG. 2
FIG. 2
a hnRNP K protein is increased in human dysplastic nevus and melanoma tissues. H&E staining and immunohistochemistry was performed on a melanoma progression tissue microarray using hnRNP K antibody. Representative H&E and immunohistochemistry analysis of the hnRNP K protein in benign nevus, dysplastic nevus, and melanoma tissues were shown. Magnification: 400 ×. b Increased cytoplasmic hnRNP K protein in melanoma cells. Mel-STV (Mel) and A375 cells were fractionated, and Western blot analysis was performed using hnRNP K, eIF4E, c-myc and α-tubulin antibodies. C cytoplasm, M membrane, N nucleus, S cytoskeleton
FIG. 3
FIG. 3
a p-ERK level is higher in human dysplastic nevus and melanoma tissues. Immunohistochemistry was performed on the same melanoma progression tissue microarray using p-ERK antibody. Representative immunohistochemistry analysis of p-ERK in benign nevus, dysplastic nevus, and melanoma tissues were shown. Magnification: 200 ×. b p-ERK level does not correlate with hnRNP K protein level. The IHC scores of the hnRNP K protein level and p-ERK level of the same tissue specimens were plotted against each other. c MEK inhibitor did not decrease the accumulation of hnRNP K and eIF4E in the cytoplasm. A375 cells were treated with MEK inhibitor U0126 (10 μM) or vehicle control DMSO for 1 h and fractionated. Western blot analysis was performed using hnRNP K, eIF4E, p-ERK, ERK1/2, and α-tubulin antibodies. C cytoplasm, N nucleus
FIG. 4
FIG. 4
siRNA knock down of hnRNP K inhibited melanoma cell growth and colony formation. a A375 melanoma cells were transfected with negative control (NC) or 50 nM or 100 nM of hnRNP K siRNAs. Cells were harvested and lysed 48 h after transfection, followed by Western blot analysis using hnRNP K, c-myc, eIF4E, and α-tubulin antibodies. b A375 cells were transfected with 50 nM of negative control or hnRNP K siRNA. Then, 24 h after transfection, 2 × 104 cells were seeded into 100-mm plates in triplicate, and cell growth was monitored by counting total cell numbers every 2 or 3 days; or c 1000 cells were seeded into 100-mm plates in triplicate and incubated for 2 weeks to allow colony formation. Then media were removed, and colonies were stained with methylene blue solution. The plates were rinsed with water, and the colony number was counted. d, e Same experiments as described in b and c were repeated in primary human fibroblasts

References

    1. Bomsztyk K, Denisenko O, Ostrowski J. hnRNP K: one protein multiple processes. Bioessays. 2004;26:629–38. - PubMed
    1. Klimek-Tomczak K, Wyrwicz LS, Jain S, Bomsztyk K, Ostrowski J. Characterization of hnRNP K protein-RNA interactions. J Mol Biol. 2004;342:1131–41. - PubMed
    1. Mikula M, Dzwonek A, Karczmarski J, Rubel T, Dadlez M, Wyrwicz LS, et al. Landscape of the hnRNP K protein-protein interactome. Proteomics. 2006;6:2395–406. - PubMed
    1. Lynch M, Chen L, Ravitz MJ, Mehtani S, Korenblat K, Pazin MJ, et al. hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation. Mol Cell Biol. 2005;25:6436–53. - PMC - PubMed
    1. Baber JL, Libutti D, Levens D, Tjandra N. High precision solution structure of the C-terminal KH domain of heterogeneous nuclear ribonucleoprotein K, a c-myc transcription factor. J Mol Biol. 1999;289:949–62. - PubMed

Publication types

MeSH terms

Substances